CANF · Can-Fite BioPharma Ltd. · Documents
Market Cap
$5.73M
Shares
3.03M
Volume · Oct 21
11.17K
Avg daily vol (3M)
358.4K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 20-F | — | 2024-03-28 | 2023-12-31 | |
| 6-K | — | 2024-03-28 | — | |
| 6-K | — | 2024-03-11 | — | |
| 6-K | — | 2024-02-28 | — | |
| 6-K | — | 2024-01-30 | — | |
| 6-K | — | 2024-01-29 | — | |
| 6-K | — | 2023-12-20 | — | |
| 6-K | — | 2023-12-18 | — | |
| 6-K | — | 2023-12-04 | — | |
| 6-K | — | 2023-11-30 | — | |
| 6-K | — | 2023-11-22 | — | |
| 6-K | — | 2023-11-21 | — | |
| 6-K | — | 2023-11-21 | — | |
| 6-K | — | 2023-11-01 | — | |
| 6-K | — | 2023-10-30 | — | |
| 6-K | — | 2023-10-26 | — | |
| 6-K | — | 2023-10-10 | — | |
| 6-K | — | 2023-09-27 | — | |
| 6-K | — | 2023-09-07 | — | |
| 6-K | — | 2023-08-31 | 2023-06-30 | |
| 6-K | — | 2023-08-24 | — | |
| 6-K | — | 2023-08-18 | — | |
| 6-K | — | 2023-08-07 | — | |
| 6-K | — | 2023-07-31 | — | |
| 6-K | — | 2023-07-17 | — | |
| 6-K | — | 2023-06-29 | — | |
| 6-K | — | 2023-06-23 | — | |
| 6-K | — | 2023-06-13 | — | |
| 6-K | — | 2023-06-01 | — | |
| 6-K | — | 2023-05-30 | — | |
| 6-K | — | 2023-05-09 | — | |
| 6-K | — | 2023-05-02 | — | |
| 6-K | — | 2023-04-24 | — | |
| 6-K | — | 2023-04-10 | — | |
| 6-K | — | 2023-03-30 | — | |
| 20-F | — | 2023-03-30 | 2022-12-31 | |
| 6-K | — | 2023-03-13 | — | |
| 6-K | — | 2023-02-22 | — | |
| 6-K | — | 2023-02-21 | — | |
| 6-K | — | 2023-02-14 | — | |
| 6-K | — | 2023-01-24 | — | |
| 6-K | — | 2023-01-13 | — | |
| 6-K | — | 2023-01-13 | — | |
| 6-K | — | 2023-01-11 | — | |
| 6-K | — | 2023-01-10 | — | |
| 6-K | — | 2022-12-30 | — | |
| 6-K | — | 2022-12-28 | — | |
| 6-K | — | 2022-12-08 | — | |
| 6-K | — | 2022-11-25 | — | |
| 6-K | — | 2022-11-02 | — |
Showing 101–150 of 279 filings